Abstract
Monoclonal antibodies (mAbs) have proven to be instrumental in the advancement of research, diagnostic, industrial vaccine, and therapeutic applications. The use of mAbs in laboratory protocols has been growing in an exponential fashion for the last four decades. Described herein are methods for the development of highly specific mAbs through traditional hybridoma fusion. For ultimate success, a series of simultaneously initiated protocols are to be undertaken with careful attention to cell health of both the myeloma fusion partner and immune splenocytes. Coordination and attention to detail will enable a researcher with basic tissue culture skills to generate mAbs from immunized rodents to a variety of antigens (including proteins, carbohydrates, DNA, and haptens) (see Note 1). Furthermore, in vivo and in vitro methods used for antigen sensitization of splenocytes prior to somatic fusion are described herein.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Kohler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495–497
Lane RD (1985) A short duration polyethylene glycol fusion technique for increasing production of monoclonal antibody-secreting hybridomas. J Immunol Meth 81:223–228
Jennings MV (1995) Review of selected adjuvants used in antibody production. ILAR J V37(3):1–9
Harlow E, Lane D (1988) Antibodies: a laboratory manual. Cold Spring Harbour Laboratory Press, New York
Schunk MK, Macallum GE (2005) Applications and optimization of immunization procedures. ILAR J 46(3):241–257
Sanchez-Madrid F, Szklut P, Springer TA (1983) Stable hamster-mouse hybridomas producing IgG and IgM hamster monoclonal antibodies of defined specificity. J Immunol 130:309
Borrebaeck CA (1983) In vitro immunization for the production of antigen-specific lymphocyte hybridomas. Scand J Immunol 18(1):9–12
Brown MC, Joaquim TR, Chambers R, Onisk DV, Yin F et al (2011) Impact of immunization technology and assay application on antibody performance—a systematic comparative evaluation. PLoS ONE 6(12):e28718. doi:10.1371/journal.pone.0028718
Ferber PC, Ossent P, Homberger FR, Fischer RW (1999) The generation of monoclonal antibodies in mice: influence of adjuvants on the immune response, fusion efficiency and distress. Lab Anim 33(4):334–350
Berry JD (2005) Rational monoclonal antibody (mAb) development to agents of foreign animal disease, bio-threat agents (BTA), and emerging infectious threats: The antigen scale. The Veterinary Journal Vol 170(2):193–211
Rieger M, Cervino C, Sauceda JC, Niessner R, Knopp D (2009) Efficient hybridoma screening technique using capture antibody based microarrays. Anal Chem 81:2373–2377
Yokoyama WM, Christensen M, Santos GD, Miller D. Production of Monoclonal Antibodies 2006. Curr Protoc Immunol 2:25
Nilsson BO, Larsson A (1990) Intrasplenic immunization with minute amounts of antigen. Trends Immunol 11(1):13–20
Simkins SG, Knapp SL, Brough GH, Lenz KL, Barley-Maloney L, Baker JP, Dekking L, Wai H, Dixon EP (2011) Generation of monoclonal antibodies to the AML1-ETO fusion protein: strategies for overcoming high homology. Hybridoma (Larchmt) 30(5):433–443
Kilpatrick KE, Wring SA, Walker DH, Macklin MD, Payne JA, Su J-L, Champion BR, Caterson B, Mclntyre GD (1997) Rapid development of affinity matured monoclonal antibodies using RIMMS. Hybridoma 16: 381–389, http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0028718
De Boer M, Ten Voorde GH, Ossendorp FA, Van Duijn G, Tager JM (1988) Requirements for the generation of memory B cells in vivo and their subsequent activation in vitro for the production of antigen-specific hybridomas. J Immunol Methods 113(1):143–149
Galfre G, Milstein C (1981) Immunochemical techniques Part B. Methods Enzymol 73:3
Kearney JF, Radbruch A, Liesegang B, Rajewsky K (1979) A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J Immunol 124(4):1548–1550
Leo O, Foo M, Sachs DH, Samelson LE, Bluestone JA (1987) Identification of a monoclonal antibody specific for murine T3 polypeptide T-cell antigen receptor/mouse/T-cell activation). Proc Natl Acad Sci U S A 84: 1374–1378
Yuan X, Gubbins MJ, Berry JD (2004) A simple and rapid protocol for the sequence determination of functional kappa light chain cDNAs from aberrant-chain-positive murine hybridomas. J Immunol Methods 294((1-2)): 199–207
http://pathology.wustl.edu/research/hybridoma.php?page=fusion
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, New York
About this protocol
Cite this protocol
Chronopoulou, E., Uribe-Benninghoff, A., Corbett, C.R., Berry, J.D. (2014). Hybridoma Technology for the Generation of Rodent mAbs via Classical Fusion. In: Ossipow, V., Fischer, N. (eds) Monoclonal Antibodies. Methods in Molecular Biology, vol 1131. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-992-5_4
Download citation
DOI: https://doi.org/10.1007/978-1-62703-992-5_4
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-991-8
Online ISBN: 978-1-62703-992-5
eBook Packages: Springer Protocols